EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy

Lintao Li iD, Junjie Li, Xianliang Wang, Shun Lu, Juan Ji, Gang Yin, Huaichao Luo, Wang Ting, Zhang Xin, Dongsheng Wang

Journal of Biophotonics · 2024

DOI: 10.1002/jbio.202300287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biophotonics, 2024. Verfasst von Lintao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer …. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu Science and Technology Bureau Technology Innovation R&D Project, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given the significant therapeutic efficacy of anti‐HER‐2 treatment, the HER‐2 status is a crucial piece of information that must be obtained in breast cancer patients. Currently, as per guidelines, HER‐2 status is typically acquired from breast tissue of patients. However, there is growing interest in obtaining HER‐2 status from serum and other samples due to the convenience and potential for dynamic monitoring. In this study, we have developed a serum Raman spectroscopy technique that allows for the rapid acquisition of HER‐2 status in a convenient manner. The established HER‐2 negative and positive classification model achieved an area under the curve of 0.8334. To further validate the reliability of our method, we replicated the process using immunohistochemistry and in situ hybridization. The results demonstrate that serum Raman spectroscopy, coupled with artificial intelligence algorithms, is an effective technical approach for obtaining HER‐2 status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansArtificial IntelligenceIn Situ HybridizationErb-b2 Receptor Tyrosine KinasesReproducibility of ResultsSpectrum Analysis, Raman

Stichwörter der Autor:innen

HER‐2Raman spectroscopybreast cancerclassification model

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospita…
  • Department of Mammary Gland Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology…
  • Department of Pathology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, C…
  • Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology o…
  • School of Pharmacy, Macau University of Science and Technology, Taipa, Macau, China.
  • State Key Laboratory for Quality Research of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China.

ORCID-Profile: Lintao Li

Förderung

  • Chengdu Science and Technology Bureau Technology Innovation R&D Project
  • Sichuan Science and Technology Program

Zitieren

APA

Li, L., Li, J., Wang, X., Lu, S., Ji, J., Yin, G., Luo, H., Ting, W., Xin, Z., & Wang, D. (2024). Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy. Journal of Biophotonics. https://doi.org/10.1002/jbio.202300287

Vancouver

Li L, Li J, Wang X, Lu S, Ji J, Yin G, et al. Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy. Journal of Biophotonics. 2024. doi:10.1002/jbio.202300287

BibTeX
@article{Li2024,
  author = {Li, Lintao and Li, Junjie and Wang, Xianliang and Lu, Shun and Ji, Juan and Yin, Gang and Luo, Huaichao and Ting, Wang and Xin, Zhang and Wang, Dongsheng},
  title = {Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy},
  journal = {Journal of Biophotonics},
  year = {2024},
  doi = {10.1002/jbio.202300287}
}
Kostenlos starten →